A detailed history of Pictet North America Advisors Sa transactions in Novo Nordisk A S stock. As of the latest transaction made, Pictet North America Advisors Sa holds 55,302 shares of NVO stock, worth $5.63 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
55,302
Previous 55,217 0.15%
Holding current value
$5.63 Million
Previous $7.88 Billion 16.45%
% of portfolio
0.65%
Previous 0.86%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$119.07 - $145.42 $10,120 - $12,360
85 Added 0.15%
55,302 $6.58 Billion
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $6.78 Million - $8.11 Million
55,217 New
55,217 $7.88 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pictet North America Advisors Sa Portfolio

Follow Pictet North America Advisors Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet North America Advisors Sa with notifications on news.